Sunfox Technologies raises $7M Series A for ECG platform Spandan
Dehradun-based medtech startup Sunfox Technologies has raised $7 Mn (around ₹67 Cr) in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital.
What Sunfox does
Sunfox develops portable and AI-enabled cardiac diagnostic solutions. Its Spandan devices allow users and healthcare workers to record ECGs using a smartphone and share them with doctors for remote interpretation. According to the startup, the platform can flag cardiac patterns requiring urgent attention.
Its digital service platform, Spandan One, supports remote ECG reviews, case coordination, and tele-ECG network management. In public health settings, nurses or health workers can record ECGs at primary and community health centres and send them to doctors or cardiologists at district hubs for review.
Sunfox said it has regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa, and is pursuing clearances in the US and the European Union.
Newsletter
The corridor, every morning.
Funding rounds and cross-border capital moves, one email, five minutes.
Sunfox claims around 60,000 Spandan devices have been deployed across India, reaching more than 20,000 villages. Its Spandan One platform is used to screen around 5 Mn patients annually, it added.
The fresh capital will be used to expand Spandan across India, grow the team, and invest in R&D, clinical evidence, engineering, and new cardiac technologies. The startup will also build regulatory, distribution, and commercial capabilities across the US, Europe, and Africa.
The raise follows a ₹15 Cr (around $1.8 Mn) round led by Venture Catalysts in 2024. Sunfox secured investment from all five participating investors on the first season of Shark Tank India.
The startup competes with Agatsa, which offers SanketLife devices, and Cardiotrack, which provides handheld ECG devices and remote interpretation solutions. Sunfox also claims a presence in more than 15 countries.
More in Funding
